Evidence map›Paper›PMID 19189970›Full record

ReviewThe Journal of biological chemistry2009

Intramembrane proteolysis by signal peptide peptidases: a comparative discussion of GXGD-type aspartyl proteases.

Regina Fluhrer, Harald Steiner, Christian Haass

Abstract readComparative StudyReview
In one paragraph

Review in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Genome-Wide Identification of the SPP/SPPL Gene Family andInternational journal of molecular sciences · 2024
    Article
  2. Frontiers in immunology · 2024
    Article
  3. Review
  4. Covalent fragment inhibits intramembrane proteolysis.Frontiers in molecular biosciences · 2022
    Article
  5. The Nuclear Translocation of Heme Oxygenase-1 in Human Diseases.Frontiers in cell and developmental biology · 2022
    Review
  6. Article
  7. Review
  8. Structural and Chemical Biology of Presenilin Complexes.Cold Spring Harbor perspectives in medicine · 2017
    Review
  9. Article
  10. The membrane anchor of the transcriptional activator SREBP is characterized by intrinsic conformational flexibility.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Structural biology of presenilin 1 complexes.Molecular neurodegeneration · 2014
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Regina FluhrerDeutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Adolf Butenandt Institute, Biochemistry, Ludwig-Maximilians University, Munich, 80336 Munich, Germany. regina.fluher@med.uni-muech.de
Harald Steiner
Christian Haass

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intramembrane-cleaving proteases are required for reverse signaling and membrane protein degradation. A major class of these proteases is represented by the GXGD-type aspartyl proteases. GXGD describes a novel signature sequence that distinguishes these proteases from conventional aspartyl proteases. Members of the family of the GXGD-type aspartyl proteases are the Alzheimer disease-related gamma-secretase, the signal peptide peptidases and their homologs, and the bacterial type IV prepilin peptidases. We will describe the major biochemical and functional properties of the signal peptide peptidases and their relatives. We then compare these properties with those of gamma-secretase and discuss common mechanisms but also point out a number of substantial differences.

Indexed as

Protein Processing, Post-TranslationalAmino Acid MotifsAmino Acid SequenceAnimalsAspartic Acid EndopeptidasesCell MembraneHumansMolecular Sequence DataAspartic Acid Endopeptidasessignal peptide peptidase

Identifiers

PMID19189970
PMCPMC2682845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.